4 Einträge gefunden

1. Prognostic effect of whole chromosomal aberration signatures in standard-risk, non-WNT/non-SHH medulloblastoma: a retrospective, molecular analysis of the HIT-SIOP PNET 4 trial

   1. Goschzik, Tobias
   2. Schwalbe, Edward C
   3. Hicks, Debbie
   4. Smith, Amanda
   5. Zur Muehlen, Anja
   6. Figarella-Branger, Dominique
   7. Doz, François

   2018 - Forschungsinformationssystem des UKE - frei zugänglich
2. Biomarker-driven stratification of disease-risk in non-metastatic medulloblastoma: Results from the multi-center HIT-SIOP-PNET4 clinical trial

   1. Clifford, Steven C
   2. Lannering, Birgitta
   3. Schwalbe, Ed C
   4. Hicks, Debbie
   5. O'Toole, Kieran
   6. Nicholson, Sarah Leigh
   7. Goschzik, Tobias

   2015 - Forschungsinformationssystem des UKE
3. Quality of survival and growth in children and young adults in the PNET4 European controlled trial of hyperfractionated versus conventional radiation therapy for standard-risk medulloblastoma

   1. Kennedy, Colin
   2. Bull, Kim
   3. Chevignard, Mathilde
   4. Culliford, David
   5. Dörr, Helmuth G
   6. Doz, François
   7. Kortmann, Rolf-Dieter

   2014 - Forschungsinformationssystem des UKE
4. Hyperfractionated versus conventional radiotherapy followed by chemotherapy in standard-risk medulloblastoma: results from the randomized multicenter HIT-SIOP PNET 4 trial.

   1. Lannering, Birgitta
   2. Rutkowski, Stefan
   3. Doz, Francois
   4. Pizer, Barry
   5. Gustafsson, Göran
   6. Navajas, Aurora
   7. Massimino, Maura

   2012 - Forschungsinformationssystem des UKE